RTW Investments’s Akoya BioSciences AKYA Stock Holding History

RTW Investments’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-338,422	Closed	-$1.57M	–	65
2023 Q3	$1.57M	Hold	338,422	–	–	0.03%	62
2023 Q2	$2.5M	Buy	338,422 +10,000	+3%	+$66.8K	0.05%	58
2023 Q1	$2.69M	Sell	328,422 -155,393	-32%	-$1.62M	0.06%	54
2022 Q4	$4.63M	Hold	483,815	–	–	0.09%	64
2022 Q3	$5.68M	Buy	483,815 +250,258	+107%	+$3.3M	0.13%	65
2022 Q2	$3M	Buy	233,557 +155,881	+201%	+$1.62M	0.08%	90
2022 Q1	$854K	Sell	77,676 -22,324	-22%	-$259K	0.02%	99
2021 Q4	$1.53M	Hold	100,000	–	–	0.02%	114
2021 Q3	$1.4M	Hold	100,000	–	–	0.02%	114
2021 Q2	$1.93M	Buy	+100,000	New	+$2.06M	0.03%	107

Other funds holding AKYA

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RTW Investments's AKYA Position: Q4 2023 in Review

RTW Investments sold out of Akoya BioSciences (AKYA) in Q4 2023, closing a stake of 338,422 shares — an estimated $1.57M sold.

RTW Investments first reported a position in AKYA in Q2 2021 and held it in 10 quarters. The position peaked at $5.68M in Q3 2022. 65 funds tracked by Wall St. Rank hold AKYA as of Q4 2023.

RTW Investments reported no remaining Akoya BioSciences position as of Q4 2023 after selling out during the quarter.
RTW Investments sold 338,422 Akoya BioSciences shares in Q4 2023, an estimated $1.57M.
RTW Investments first reported a position in Akoya BioSciences in Q2 2021 and held it in 10 quarters.
RTW Investments's Akoya BioSciences position peaked at $5.68M in Q3 2022.
65 funds tracked by Wall St. Rank held Akoya BioSciences as of Q4 2023.

Based on RTW Investments's 13F filing for Q4 2023, filed 14 Feb 2024.